Nutrition and cardiac cachexia

Purpose of reviewCongestive heart failure is a leading cause of morbidity and mortality, especially in older persons. In advanced stages of the disease, congestive heart failure can be associated with serious complications such as cardiac cachexia (defined here as weight loss of more than 6% in 6 months). This review will discuss recent insights into the pathophysiology, anthropometric predictors and potential management of cardiac cachexia. Recent findingsCardiac cachexia and the associated progressive weight loss are sometimes overlooked by care providers. A delay in diagnosis often results in further loss of vital tissues, progressive weakness, fall-related injuries and potentially long-term care institutionalization and/or death. Emerging data suggest that congestive heart failure is a dynamic disorder of many organ systems, including the myocardial, neurohormonal, immune, vascular, gastrointestinal, renal and musculoskeletal systems. It is becoming more widely appreciated that it is the deterioration of this interactive multisystem complex that results in the systemic inflammation and progressive wasting and atrophy of muscle and other organ tissues, which is the hallmark of cardiac cachexia. SummaryCardiac cachexia in congestive heart failure patients may be associated with a low level of physical activity. A high systemic inflammatory state is another marker of cardiac cachexia. Prudent anti-inflammatory nutrition, dietary supplements and exercise can serve to ameliorate and/or potentially prevent progressive wasting. A better understanding of factors contributing to the development of cardiac cachexia will enable us to design preventive strategies and provide improved care for individuals with this debilitating condition.

[1]  G. Pulignano,et al.  Functional mitral regurgitation predicts 1‐year mortality in elderly patients with systolic chronic heart failure , 2005, European journal of heart failure.

[2]  S. Anker,et al.  The importance of the gastrointestinal system in the pathogenesis of heart failure. , 2005, European heart journal.

[3]  S. Anker,et al.  Muscle wasting in cardiac cachexia. , 2005, The international journal of biochemistry & cell biology.

[4]  P. Schulze,et al.  Insulin-like growth factor-1 and muscle wasting in chronic heart failure. , 2005, The international journal of biochemistry & cell biology.

[5]  G. Pulignano,et al.  Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure , 2005, European journal of heart failure.

[6]  R. Goldberg,et al.  Incidence and hospital death rates associated with heart failure: a community-wide perspective. , 2005, The American journal of medicine.

[7]  J. Manson,et al.  Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. , 2005, The American journal of clinical nutrition.

[8]  D. Mozaffarian,et al.  Fish intake and risk of incident heart failure. , 2005, Journal of the American College of Cardiology.

[9]  J. Jordan,et al.  Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  D. King Dietary fiber, inflammation, and cardiovascular disease. , 2005, Molecular nutrition & food research.

[11]  Arch G. Mainous,et al.  Dietary Magnesium and C-reactive Protein Levels , 2005, Journal of the American College of Nutrition.

[12]  Lawrence A Leiter,et al.  Direct comparison of dietary portfolio vs statin on C-reactive protein , 2005, European Journal of Clinical Nutrition.

[13]  M. Houston Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. , 2005, Progress in cardiovascular diseases.

[14]  G. Filippatos,et al.  Pathophysiology of peripheral muscle wasting in cardiac cachexia , 2005, Current opinion in clinical nutrition and metabolic care.

[15]  A. Coats Advances in the non-drug, non-surgical, non-device management of chronic heart failure. , 2005, International journal of cardiology.

[16]  P. Hildebrandt,et al.  Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure. , 2005, International journal of cardiology.

[17]  D. Rakel,et al.  Featured CME Topic: Complementary and Alternative Medicine Inflammation: Nutritional, Botanical, and Mind-body Influences , 2005 .

[18]  Jennifer G. Robinson,et al.  A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years. , 2005, The American journal of cardiology.

[19]  A. Mokdad,et al.  Healthy Eating Index and C-reactive protein concentration: findings from the National Health and Nutrition Examination Survey III, 1988–1994 , 2005, European Journal of Clinical Nutrition.

[20]  N. Rosenthal,et al.  Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. , 2005, The Journal of clinical investigation.

[21]  S. Bloom,et al.  The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension , 2005, Heart.

[22]  D. Mozaffarian,et al.  Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. , 2005, Archives of internal medicine.

[23]  D. J. Veldhuisen,et al.  Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT‐ANP and BNP/NT‐proBNP , 2005, European journal of heart failure.

[24]  L. Castillo-Martínez,et al.  Anthropometric variables and physical activity as predictors of cardiac cachexia. , 2004, International journal of cardiology.

[25]  J. Ketelslegers,et al.  Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study. , 2004, Journal of cardiac failure.

[26]  D. Pennell,et al.  Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. , 2004, International Journal of Cardiology.

[27]  Jeanne Y Wei Understanding the aging cardiovascular system , 2004 .

[28]  S. Anker,et al.  Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. , 2004, International journal of cardiology.

[29]  J. Gums Magnesium in cardiovascular and other disorders. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[30]  Roger B. Johnson,et al.  The relationship between tomato intake and congestive heart failure risk in periodontitis subjects. , 2004, Journal of clinical periodontology.

[31]  C. Opasich,et al.  Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure. , 2004, The American journal of cardiology.

[32]  Kamyar Kalantar-Zadeh,et al.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. , 2004, Journal of the American College of Cardiology.

[33]  N. Christensen,et al.  Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability , 2004, Scandinavian journal of clinical and laboratory investigation.

[34]  A. Tenenbaum,et al.  Impaired Glucose Metabolism in Patients with Heart Failure , 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[35]  Lilia Castillo Martínez,et al.  Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failure. , 2004, Nutrition.

[36]  Jeanne Y Wei,et al.  Clinical Implications of Physiological Changes in the Aging Heart , 2001, Drugs & aging.

[37]  M. Sherman,et al.  Suppression of Stress Kinase JNK Is Involved in HSP72-mediated Protection of Myogenic Cells from Transient Energy Deprivation , 2000, The Journal of Biological Chemistry.

[38]  Simon Stewart,et al.  Epidemiology, aetiology, and prognosis of heart failure , 2000, Heart.

[39]  Jeffrey M. Hausdorff,et al.  Neutrophilia and congestive heart failure after acute myocardial infarction. , 2000, American heart journal.

[40]  Khan,et al.  Arachidonic acid metabolites alter G protein-mediated signal transduction in heart. Effects on muscarinic K+ channels , 1990, The Journal of general physiology.

[41]  Jeffrey M. Hausdorff,et al.  Congestive heart failure with preserved systolic function: is it a woman's disease? , 1999, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[42]  Jeffrey M. Hausdorff,et al.  Hypotensive response to atrial natriuretic peptide administration is enhanced with age. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[43]  Jeffrey M. Hausdorff,et al.  Increased Walking Variability in Elderly Persons with Congestive Heart Failure , 1994, Journal of the American Geriatrics Society.

[44]  M. Winker,et al.  Age and the cardiovascular system. , 1993, The New England journal of medicine.

[45]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[46]  J. Rowe,et al.  The effect of age and sodium depletion on cardiovascular response to orthostasis. , 1986, Hypertension.